NCT03069144 - Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 6, 2012

Primary Completion Date

April 11, 2012

Study Completion Date

May 28, 2012

Conditions

PsoriasisPsoriasis Vulgaris

Interventions

DRUG

HAT1 topical solution

HAT1 topical solution will be applied twice daily. The research team will provide instructions for the correct application of the treatment. If a lesion disappears, patients will continue applying the cream twice daily to the area. No additional creams, lotions or soaps other than provided test products will be allowed throughout the duration of the study.

DRUG

Calcipotriol

Calcipotriol ointment (0.005%) will be applied twice daily. The research team will provide instructions for the correct application of the treatment. If a lesion disappears, patients will continue applying the cream twice daily to the area. No additional creams, lotions or soaps other than provided test products will be allowed throughout the duration of the study.